Management Team

Lawrence Bloch, MD, JD, Chief Executive Officer
John S. Andrews, PhD, President, Head of R&D
Robert A. Medve, MD, Chief Medical and Regulatory Officer
Suman Rakhit, PhD, Chief Scientific Officer
Tom Lategan DPhil, Vice President of Regulatory Affairs
Shawn Maddaford, PhD, Vice President of Discovery Chemistry

Leadership

Management Team
Board of Directors
Board Observers
Scientific Advisory Board

Suman Rakhit, PhD, Chief Scientific Officer

Founder and CEO of MCR Research Inc. a medicinal chemistry CRO. Former Director of the Medicinal Chemistry at Allelix Biopharmaceuticals and BioMega-Boehringher Ingelheim.  More than 37 years experience in drug discovery and development.  Co-discovered Rapamycin, an anti-rejection drug, at Ayerst Laboratories.  Discovered anti-migraine drug ALX-646, an antimigraine drug currently undergoing Phase II clinical trials by Allelix.  Responsible for the dopaminergic antagonist program for the treatment of Schizophrenia which was licensed to Aventis for over C$50 million in 1995. Part of a team which established Bio-Mega and its research programs, eventually acquired by Boehringer-Ingelheim.  More than 70 publications and 25 patents in synthetic chemistry and lead optimization.